Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.
By R. Timmerman, L. Papiez, R. Mcgarry, L. Likes, C. DesRosiers, S. Frost, Mark D. Williams. Chest, 2003
688 citations recorded by the source corpus.
Subfields: Hepatology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/2de4a570ac83f7434e00b78bd09507f1b2d922fd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Radiation Dose Volume Effects in the Lung (2010, background): “RP is relatively uncommon after SBRT, usually <10% (23, 24), but as high as 25% (25).”
- Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. (2009, result): “Previously we reported results of a Phase I dose escalation trial in patients with medically inoperable Stage I NSCLC ( 19 , 20).”